Cite
HARVARD Citation
Chang, J. et al. (2016). Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study. British journal of haematology. pp. 283-291. [Online].